Omniq Selected for an Approximate $50 Million Project to Modernize Supply Chain for One of the Largest us Food and Drug Chains
15 août 2023 07h00 HE
|
OMNIQ Corp.
Project expected to start immediately and continue through the end of 2024. SALT LAKE CITY, Aug. 15, 2023 (GLOBE NEWSWIRE) -- OMNIQ Corp. (NASDAQ: OMQS) (“OMNIQ” or the “Company”), a provider of...
Oncotelic Initiates Phase 1 Trial Evaluating CA4P in Combination with Pembrolizumab for Melanoma
05 janv. 2022 08h01 HE
|
Oncotelic Therapeutics, Inc.
AGOURA HILLS, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. ("Oncotelic" or the "Company") (OTCQB:OTLC), a leading developer of TGF-β therapeutics for oncology and virology,...